Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 8, 2013 (Earliest event reported: March 7, 2013)
Context: The filing reports the entry into a material definitive agreement regarding the amendment of the company's accounts receivable securitization program.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or general liquidity metrics. It specifically addresses the following debt and facility metrics:
- Facility Size Increase: The Receivables Facility was increased from $300 million to $500 million.
- Facility Termination Date: Extended to March 21, 2015.
- Collateral: Health care accounts receivable (excluding self-pay) originated by subsidiaries.
- Structure: Borrowings are funded via asset-backed commercial paper or a committed liquidity facility.
Material Changes Versus Prior Period
The primary material change is the expansion and restructuring of the existing Receivables Facility:
- Capacity Expansion: Maximum borrowing capacity increased by $200 million (from $300 million to $500 million).
- Term Extension: The scheduled termination date was extended.
- Lender Composition: The Bank of Tokyo-Mitsubishi UFJ, Ltd. was added as a new managing agent.
- Agreement Amendments: The Receivables Sale Agreement, Receivables Purchase and Contribution Agreement, and Receivables Loan Agreement were amended via a Second Omnibus Amendment.
Guidance, Outlook, Risks, and Contingencies
Management Commentary: The company intends for the transactions to be treated as "true sales" or absolute contributions to a bankruptcy-remote special purpose limited liability company (CHS Receivables Funding, LLC).
Risks and Contingencies:
- Termination Events: The facility may be terminated early due to failure to make timely payments, breach of covenants, failure to meet leverage or Receivables ratios, or certain changes of control.
- Guarantees: CHS guarantees the performance of the Collection Agent but explicitly does not guarantee the collection of receivables if uncollectible due to the insolvency or bankruptcy of the obligor.
- Fees: The company is obligated to pay upfront fees to managing agents and ongoing usage fees to lenders.
Important Facts for Investor Verification
- Verify the impact of the $200 million facility increase on the company's overall leverage ratios and debt covenants.
- Confirm the specific terms of the extended termination date (March 21, 2015) and any renewal options.
- Review the full text of the Second Omnibus Amendment (Exhibit 10.1) for detailed covenant requirements and termination triggers.
- Assess the concentration of risk regarding the new managing agent, The Bank of Tokyo-Mitsubishi UFJ, Ltd.